World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01250223
Date of registration: 26/11/2010
Prospective Registration: No
Primary sponsor: Associazione Angela Serra per la ricerca sul cancro
Public title: Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
Scientific title: F2-PROTOCOL: Prospective Collection of Data of Possible Prognostic Relevance in Patients With Follicular Lymphoma
Date of first enrolment: February 2003
Target sample size: 1093
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01250223
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Argentina Czech Republic Czechia France Italy Spain Switzerland United Kingdom
United States
Contacts
Name:     Peter McLaughlin, MD
Address: 
Telephone:
Email:
Affiliation:  UT MD Anderson Cancer Ctr, Houston, TX, USA
Name:     Armando Lopez-Guillermo, MD
Address: 
Telephone:
Email:
Affiliation:  Institut d'Hematologia i Oncologia, Hospital Clinic, Barcelona, Spain
Name:     Massimo Federico, MD
Address: 
Telephone:
Email:
Affiliation:  Dip. Oncologia, Ematologia e Patologie dell'Apparato Respiratorio - Università di Modena e Reggio Emilia, Modena, Italy
Name:     Umberto Vitolo, MD
Address: 
Telephone:
Email:
Affiliation:  Azienda Universitaria Ospedaliera San Giovanni Battista, Torino, Italy
Name:     Philippe Solal-Céligny, MD
Address: 
Telephone:
Email:
Affiliation:  Centre Jean Bernard, Le Mans, France
Name:     Stefano A. Pileri, MD
Address: 
Telephone:
Email:
Affiliation:  Instituto Seragnoli, Unità Operativa di Emolinfopatologia, Università di Bologna, Bologna, Italy
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with newly diagnosed follicular lymphoma

- Patients with histologically confirmed diagnosis of follicular lymphoma according to
WHO classification (any grade)

- Age over 18

- Written informed consent

Exclusion Criteria:

- None



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Lymphoma, Follicular
Intervention(s)
Primary Outcome(s)
Progression Free Survival (PFS) [Time Frame: 5-year]
Secondary Outcome(s)
Event Free Survival (EFS) [Time Frame: 5-year]
Treatment Free Survival [Time Frame: 5-year]
Overall Survival (OS) [Time Frame: 5-year]
Secondary ID(s)
F2-study
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Fondazione Italiana Linfomi ONLUS
The International Non-Hodgkin Lymphoma Prognostic Factor Project
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history